Experience
Merck Sharp & Dohme Corp.
GlaxoSmithKline Biologicals SA
Represented patent owner GlaxoSmithKline Biologicals SA in multiple inter partes review (IPR) proceedings involving vaccine production patents.
Merck Sharp & Dohme Corp. v. GlaxoSmithKline Biologicals SA, IPR2018-01229, -01234, -01236, -01237; IPR2019-00230, -00241, PTAB, Judges Snedden, Kokoski, Smith
Pfenex Inc. v. GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA
Feit Electric Company, Inc. v. Philips Lighting North America Corp.
Philips Lighting North America Corp.
Finnegan goes three-for-three in IPR non-institution decisions for client inMusic
inMusic Brands, Inc.
Lectrosonics, Inc. v. Zaxcom, Inc.
Lectrosonics, Inc.
Sandoz Inc. v. AbbVie Biotechnology, Ltd
AbbVie Biotechnology, Ltd
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Biogen MA Inc. et al.
Comcast Cable Communications, LLC v. Promptu Systems Corporation
Promptu Systems Corporation
South-Tek Systems, LLC v. Engineered Corrosion Solutions, LLC
Engineered Corrosion Solutions, LLC
Eli Lilly and Company v. Teva Pharmaceuticals International
Eli Lilly and Company
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.